EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults
Launched by UNIVERSITY OF SUNDERLAND · May 12, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The EQUITA trial is a study designed to find out how effective and acceptable a new program is for encouraging Black adults in certain areas of the UK to get important health screenings for breast, bowel, cervical cancers, and abdominal aortic aneurysms. The aim is to create a culturally sensitive approach that resonates with the community. Participants will attend a two-hour workshop and will be randomly placed in either a group that receives the new intervention or a control group that does not.
To join the trial, you need to be a member of one of the participating churches in the North East of England, Leeds, or Scotland, and identify as Black. Women aged 25-74 and men aged 50-74 who are not fully up to date with their screening tests can participate. This study is currently not recruiting participants yet, but it will last for 24 months and will help shape a larger trial in the future. It's a great opportunity to contribute to improving health screening rates in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Members of participating churches (North East of England, Leeds, Scotland)
- • Self-identify as Black,
- • Female aged 25-74,
- • Male aged 50-74,
- • Not up to date with all screening tests for which they are eligible, e.g., women who are up to date with one form of screening (e.g., breast) will be eligible for recruitment if they are not up to date with others (e.g., cervical or bowel).
- Exclusion Criteria:
- • Not a member of participating churches (North East of England, Leeds, Scotland).
- • Individuals who do not self-identify as Black
- • Do not self-identity as Black
- • Females aged outside the range of 25-74
- • Males aged outside the range of 50-74.
- • Individuals who are up to date with all screening tests for which they are eligible.
About University Of Sunderland
The University of Sunderland is a leading UK higher education institution committed to advancing research and innovation across various disciplines, including health and clinical sciences. With a strong emphasis on collaboration and community engagement, the university actively contributes to the development of evidence-based practices through rigorous clinical trials. Its multidisciplinary approach fosters a rich environment for academic inquiry, enabling the exploration of novel therapeutic interventions aimed at improving patient outcomes. The University of Sunderland is dedicated to maintaining the highest ethical standards and regulatory compliance in all its research endeavors, ensuring the integrity and reliability of its findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glasgow, Scotland, United Kingdom
Sunderland, , United Kingdom
Leeds, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported